These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 5153883

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L, Naplatanova D.
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Medicinal capsules].
    Khanina GI, Batkina ZV, Pospelova VV, Dedukh NG.
    Farmatsiia; 1974 Jul; (6):67-70. PubMed ID: 4618815
    [No Abstract] [Full Text] [Related]

  • 25. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X, Feng Z, Huo W, Li Y, Wang B, Zhu S.
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [Abstract] [Full Text] [Related]

  • 26. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M, Peppas NA, McGinity JW.
    J Control Release; 2006 Oct 10; 115(2):121-9. PubMed ID: 16959356
    [Abstract] [Full Text] [Related]

  • 27. Formulations and dosages of oral drugs.
    Calesnick B.
    Am Fam Physician; 1978 Sep 10; 18(3):160-2. PubMed ID: 685796
    [No Abstract] [Full Text] [Related]

  • 28. Degradation studies of azithromycin and its spectrophotometric determination in pharmaceutical dosage forms.
    Sultana N, Arayne MS, Hussain F, Fatima A.
    Pak J Pharm Sci; 2006 Apr 10; 19(2):98-103. PubMed ID: 16751118
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Resistance and disintegration behavior of gastric juice-resistant drug products. 3. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K, Heckenmüller H, Oschmann R.
    Pharmazie; 1987 Dec 10; 42(12):832-6. PubMed ID: 3444845
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic response to oral dosage forms.
    Ruedy J.
    Med Serv J Can; 1967 Mar 10; 23(3):360-2. PubMed ID: 6056378
    [No Abstract] [Full Text] [Related]

  • 32. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
    Corrigan OI, Timoney RF.
    Ir J Med Sci; 1974 Jul 10; 143(4):197-207. PubMed ID: 4605123
    [No Abstract] [Full Text] [Related]

  • 33. [Stability of acetylsalicylic acid in dosage forms].
    Rak J, Chalabala M.
    Cesk Farm; 1971 Jul 10; 20(4):154-60. PubMed ID: 5561404
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
    Schumacher GE.
    Am J Hosp Pharm; 1972 Apr 10; 29(4):339-43. PubMed ID: 5025265
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.